Blue Trust’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Blue Trust's AMGN Position: Q3 2026 in Review
Blue Trust reduced its Amgen (AMGN) stake by 14% in Q3 2026, selling an estimated $105K and leaving 1,643 shares worth $693K. The position accounts for 0.01% of the portfolio, ranked #392.
Blue Trust first reported a position in AMGN in Q2 2022 and has held it in 18 quarters since. The position peaked at $1.15M in Q3 2024. 2,911 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Blue Trust held 1,643 shares of Amgen worth $693K as of Q3 2026.
- Blue Trust sold 264 Amgen shares in Q3 2026, an estimated $105K.
- Amgen made up 0.01% of Blue Trust's portfolio in Q3 2026, its #392 holding.
- Blue Trust first reported a position in Amgen in Q2 2022 and has held it in 18 quarters since.
- Blue Trust's Amgen position peaked at $1.15M in Q3 2024.
- 2,911 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.